Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 44Neoplasms 43Lung Neoplasms 28Colorectal Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 15Ovarian Neoplasms 15Pancreatic Neoplasms 13Melanoma 11Uterine Cervical Neoplasms 10Neoplastic Cells, Circulating 9Neoplasm Metastasis 9Sarcoma 8Multiple Myeloma 8Head and Neck Neoplasms 8Glioma 8Glioblastoma 8Hematologic Neoplasms 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma 6Leukemia, Myeloid, Acute 6Endometrial Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Gastrointestinal Neoplasms 5Disease 5Brain Neoplasms 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Peritoneal Neoplasms 4

Interventions

Vincristine 1Vinblastine 1Procarbazine 1Prednisone 1Methotrexate 1Mercaptopurine 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Blood Specimen Collection 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ataxia Telangiectasia × Blood Specimen Collection × Clear all
NCT03357978 2017-11-30

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Johann Wolfgang Goethe University Hospital

Phase NA Unknown
30 enrolled

Ataxia Telangiectasia, Immunologic Deficiency Syndromes, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡